Private Equity KKR, Hologic, Ajax Health Create Maverix Medical PlatformMaverix will develop and acquire technologies and commercial operations within the lung cancer disease category. November 30, 2023
Healthcare Bristol Myers Pays $4.1B for Lung-Cancer BiotechBristol Myers will pay $76 a share in cash to acquire all outstanding Turning Point shares. June 3, 2022